Vir Biotechnology
VIR
VIR
203 hedge funds and large institutions have $2.09B invested in Vir Biotechnology in 2022 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 83 increasing their positions, 44 reducing their positions, and 49 closing their positions.
Holders
203
Holders Change
-6
Holders Change %
-2.87%
% of All Funds
3.21%
Holding in Top 10
4
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-42.86%
% of All Funds
0.06%
New
47
Increased
83
Reduced
44
Closed
49
Calls
$16.7M
Puts
$10.3M
Net Calls
+$6.41M
Net Calls Change
+$7.59M
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SSG
251
Summit Securities Group
New York
| – | – | – | – |
|
|
CM
252
Caption Management
Oklahoma City,
Oklahoma
| – | – | – | – |
|
253
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $0 | 1 | – | – |
|
|
TLP
254
Tri Locum Partners
New York
| – | – | – | – |
|
|
HT
255
HAP Trading
New York
| – | – | – | – |
|
|
GWS
256
Glassman Wealth Services
Vienna,
Virginia
| $0 | 1 | +1 | New |
|
257
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $0 | 7 | +7 | New |
|
|
VCM
258
Versant Capital Management
Phoenix,
Arizona
| $0 | 12 | +12 | New |
|